ACADIA Pharmaceuticals
ACAD
#3635
Rank
S$4.55 B
Marketcap
S$26.74
Share price
-3.35%
Change (1 day)
16.13%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Cash on Hand

Cash on Hand as of December 2025 : S$1.05 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company has S$1.05 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ACADIA Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31S$1.05 B2.41%
2024-12-31S$1.02 B77.29%
2023-12-31S$0.57 B3.73%
2022-12-31S$0.55 B-20.62%
2021-12-31S$0.70 B-15.8%
2020-12-31S$0.83 B-11.08%
2019-12-31S$0.94 B45.35%
2018-12-31S$0.64 B41.69%
2017-12-31S$0.45 B-40.37%
2016-12-31S$0.76 B151.61%
2015-12-31S$0.30 B-28.58%
2014-12-31S$0.42 B81.02%
2013-12-31S$0.23 B78.28%
2012-12-31S$0.13 B228.37%
2011-12-31S$40.2 M-15.83%
2010-12-31S$47.77 M-27.69%
2009-12-31S$66.06 M-23.11%
2008-12-31S$85.92 M-52.93%
2007-12-31S$0.18 B42.99%
2006-12-31S$0.12 B78.31%
2005-12-31S$71.59 M22.15%
2004-12-31S$58.61 M26.77%
2003-12-31S$46.23 M114.22%
2002-12-31S$21.58 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$25.90 B 2,352.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$17.51 B 1,558.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$9.36 B 786.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$13.75 B 1,202.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S$0.37 B-64.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA